Home Medicines Spineology Announces Key Leadership Appointment and Welcomes New Vice President of Marketing

Spineology Announces Key Leadership Appointment and Welcomes New Vice President of Marketing

16
0


Appointments support accelerated growth of proprietary mesh technology

August 2, 2022

ST. PAUL, Minn.–(BUSINESS WIRE)–Spineology Inc., the longtime leader in ultra-minimally invasive spine surgery, announces the promotion of Matt Cronin to Chief Commercial Officer. Cronin will lead Spineology’s commercial team of sales, marketing and medical education, driving the company’s commercial strategy.

“Having worked with Matt the last year and a half in his role as Senior Vice President of Sales, I know his leadership will accelerate the already rapid growth of our proprietary mesh technologies, OptiMesh® and Duo™ Ti interbody fusion implants,” said Spineology CEO John Booth. “Matt’s distinguished record of success in positioning medical device companies to achieve sustainable revenue and dynamic growth makes him perfectly suited to direct our commercial strategy while delivering products, services and programs that meet the needs of our customers and their patients.”

Spineology also announces the appointment of Jonathan Arndt as Vice President of Marketing. Arndt joins Spineology having 19 years of medical device experience as a top performer in both marketing and sales leadership positions.

“It is an exciting time to be joining Spineology,” Arndt said. “We are focused on transforming the patient and physician experience through our differentiated portfolio. Spineology sits at the intersection of how our physician customers treat their patients and where their patients can be treated.”

“I am honored for the opportunity to lead Spineology’s commercial team,” said Spineology CCO Matt Cronin. “We have a formidable team, with Jon’s expertise in building marketing organizations and strategies coupled with the extensive product and procedural knowledge of Dan McPhillips, our VP of Medical Education and Medical Affairs. We are poised to capitalize on our recent FDA De Novo Grant for OptiMesh by penetrating the fusion market with our differentiated ultra-minimally invasive product portfolio, providing impactful treatment solutions to our surgeon customers and their patients.”

About Spineology Inc.

At Spineology, we are dedicated to transforming spine surgery by providing innovative, anatomy-conserving technologies for surgeons and their patients. Our proprietary mesh technology is used in the OptiMesh and Duo implants, which expand in three dimensions to create large footprints and allow placement of anatomy-conforming interbody fusion devices through very small incisions. This technology preserves spinal anatomy, increases procedural efficiency, and accelerates patient recovery. Learn more at spineology.com.

Contacts
John J. Booth, Chief Executive Officer
651-256-8511
jbooth@spineology.com

Previous articlePerfect Jasmine Rice – Once Upon a Chef
Next articleMusic Festivals Embrace Overdose Reversal Drugs, but Fentanyl Testing Kits Remain Taboo